(Q38447860)

3 September 2017

PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer (English)

1 reference

3 September 2017

1 reference

12

1 reference

3 September 2017

13

1 reference

Australian Prostate Cancer BioResource

3 September 2017

11

object named as

Australian Prostate Cancer BioResource

0 references

Hyeongsun Moon

object named as

H Moon

1

0 references

author name string

C S Lee

2

1 reference

3 September 2017

K L Inder

3

1 reference

3 September 2017

S Sharma

4

1 reference

3 September 2017

E Choi

5

1 reference

3 September 2017

D M Black

6

1 reference

3 September 2017

K-A Lê Cao

7

1 reference

3 September 2017

C Winterford

8

1 reference

3 September 2017

J I Coward

9

1 reference

3 September 2017

M T Ling

10

1 reference

3 September 2017

Australian Prostate Cancer BioResource

11

1 reference

3 September 2017

P J Russell

14

1 reference

3 September 2017

M M Hill

15

1 reference

3 September 2017

language of work or name

English

0 references

publication date

12 August 2013

1 reference

3 September 2017

1 reference

3 September 2017

33

1 reference

3 September 2017

3561-3570

1 reference

3 September 2017

27

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.315

3 September 2017

0 references

cites work

Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

The multiple faces of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Interleukin-6: a multifunctional targetable cytokine in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

The role of caveolin-1 in androgen insensitive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Caveolin-1 promotes autoregulatory, Akt-mediated induction of cancer-promoting growth factors in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Interleukin-6 and prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Caveolin-1 in tumor progression: the good, the bad and the ugly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

SDPR induces membrane curvature and functions in the formation of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Down-regulation of the cavin family proteins in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

A microarray-based DNA methylation study of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Androgen receptor and caveolin-1 in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

A high-throughput platform for lentiviral overexpression screening of the human ORFeome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Generation of a genome scale lentiviral vector library for EF1α promoter-driven expression of human ORFs and identification of human genes affecting viral titer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Characterization of the role of IL-6 in the progression of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.315

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.315

1 reference

Dimensions Publication ID

3 September 2017

1038007438

0 references

Fatcat ID

release_25yg6xnzhbh5vh4ytquqjtxjjy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/25yg6xnzhbh5vh4ytquqjtxjjy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference